The Saudi Society of Medical Genetics Annual Conference 2023 was held in Riyadh, Saudi Arabia, on September 29-30, 2023. As the most authoritative academic conference on precision medicine in the Kingdom, this conference attracted global experts worldwide.

Mr. Luo with the Assistant Secretary-General of Saudi Health Council, Dr. Moataz Billah Al-Ruwaithi, Director of Applied and Clinical Research of Riyadh Hospital Cluster II, Dr. Saleh Alghamdi, President of SSMG, Dr. Amal Alhashem and others in a group photo.

One of the highlights of the conference was the presentation entitled "Spatial-temporal sequencing and some large-scale application of precision medicine technologies," delivered by Dr. Louis (Renyuan) Luo, VP of BGI Genomics West Asia, at the invitation of the Saudi Society of Medical Genetics.

Mr. Luo delivering the presentation during event.

Dr. Luo's presentation discussed the importance of spatiotemporal sequencing technology in the field of precision medicine and its potential large-scale applications, introduced the company's case studies, such as the world's first multi-center project of newborn genetic screening, large-scale regional noninvasive prenatal testing (NIPT) coverage and extensive early screening project of colorectal cancer at Wuhan, Hubei province, China.

Besides sharing BGI Genomics research achievements and innovative applications in enhancing medical outcomes, Dr. Luo highlighted Genalive, BGI Genomics joint venture laboratory in the Kingdom of Saudi Arabia. This is the result of a localized strategic partnership aiming to provide cutting-edge precision medicine services, promote development and contribute to improving the country's healthcare system.

Mr. Luo with the Assistant Secretary-General of Saudi Health Council, Dr. Moataz Billah Al-Ruwaithi, Director of Applied and Clinical Research of Riyadh Hospital Cluster II, Dr. Saleh Alghamdi, President of SSMG, Dr. Amal Alhashem and others in a group photo.

The success of Dr. Luo's presentation paves the way for deepening future localized collaboration and innovation in Saudi Arabia. BGI Genomics will continue to support the realization of Saudi Vision 2030 through active participation in global cooperation and exchanges in the field of precision medicine to enhance patients' health outcomes.

About BGI Genomics:

BGI Genomics, headquartered in Shenzhen, China, is the world's leading integrated solutions provider of precision medicine. Our services cover more than 100 countries and regions, involving more than 2,300 medical institutions. In July of 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) was officially listed on the Shenzhen Stock Exchange.

Read more:

From Saudi Arabia to Serbia – How BRI Enhances Healthcare and Lives

BGI Genomics Unveils Genalive's Cutting-Edge Clinical Lab in Saudi Arabia

Men's Health Matters: Spotting Prostate, Colorectal, and Heart Threats in Saudi Arabia

Ramadan Mubarak to Muslims worldwide and learn how fasting affects your gut!